US magazine Newsweek highlights Cuba’s contribution to fight pandemic

Washington, Mar 27 (Prensa Latina) US magazine Newsweek on Friday highlights Cuba’s contribution to globally confront the coronavirus pandemic known as SARS-Cov-2 despite the blockade.

Cuba uses the ‘wonder drug’ to fight the novel coronavirus worldwide despite Washington sanctions, states a comprehensive article signed by Tom O’Connor, which values the island’s successes and its contribution to the world in these moments of crisis despite strict sanctions.

The drug, called Interferon Alpha-2B Recombinant (IFNrec), is jointly developed by scientists from Cuba and China, where the coronavirus disease outbreak first emerged late last year, the publication said. Cuba first used advanced interferon techniques to treat dengue fever in the 1980s and later found success in using it to combat HIV, human papillomavirus, Hepatitis B, Hepatitis C and other diseases, the note says.

The use of Interferon Alpha-2B Recombinant ‘prevents aggravation and complications in patients who reach this stage, which can ultimately result in death,’ Cuban biotechnology expert Luis Herrera Martinez told the publication.

Interferon Alpha-2B Recombinant has not been approved to treat the pandemic, but has been shown to be effective against viruses similar to it.

However, Cuba’s anti-pandemic ambitious efforts have been hampered by sanctions Washington has imposed for decades, which a Cuban official described Newsweek as ‘the main obstacle not only in responding to major health crises such as Covid-19, but also for the development of the country in any area,’ the publication denounces.

The Cuban Ministry of Foreign Affairs has regularly rejected such accusations, arguing that the Washington blockade was instead the true violation of international law and highlighting Havana’s humanitarian contributions, the publication states.


This entry was posted in Healthcare. Bookmark the permalink.